p53 is a key molecular target of ursodeoxycholic acid in regulating apoptosis

被引:63
作者
Amaral, Joana D.
Castro, Rui E.
Sola, Susana
Steer, Clifford J.
Rodrigues, Cecilia M. P.
机构
[1] Univ Lisbon, Fac Pharm, P-1649003 Lisbon, Portugal
[2] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Sch Med, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA
关键词
D O I
10.1074/jbc.M704075200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
p53 plays an important role in regulating expression of genes that mediate cell cycle progression and/or apoptosis. In addition, we have previously shown that the hydrophilic bile acid ursodeoxycholic acid (UDCA) prevents transforming growth factor beta 1-induced p53 stabilization and apoptosis in primary rat hepatocytes. Therefore, we hypothesized that p53 may represent an important target in bile acid-induced modulation of apoptosis and cell survival. In this study we demonstrated that UDCA reduces p53 transcriptional activity, thereby preventing its ability to induce Bax expression, mitochondrial translocation, cytochrome c release, and apoptosis in primary rat hepatocytes. More importantly, bile acid inhibition of p53-induced apoptosis was associated with decreased p53 DNA binding activity. Subcellular localization of p53 was also altered by UDCA. Both events appear to be related with increased association between p53 and its direct repressor, Mdm-2. In conclusion, these results further clarify the antiapoptotic mechanism of UDCA and suggest that modulation of Mdm-2/p53 interaction is a prime target for this bile acid.
引用
收藏
页码:34250 / 34259
页数:10
相关论文
共 64 条
[1]  
Amaral Joana D, 2007, Expert Rev Endocrinol Metab, V2, P487, DOI 10.1586/17446651.2.4.487
[2]   Activation and activities of the p53 tumour suppressor protein [J].
Bálint, É ;
Vousden, KH .
BRITISH JOURNAL OF CANCER, 2001, 85 (12) :1813-1823
[3]   Apoptosis: checkpoint at the mitochondrial frontier [J].
Bossy-Wetzel, E ;
Green, DR .
MUTATION RESEARCH-DNA REPAIR, 1999, 434 (03) :243-251
[4]  
BOTLA R, 1995, J PHARMACOL EXP THER, V272, P930
[5]   An intact HDM2 RING-finger domain is required for nuclear exclusion of p53 [J].
Boyd, SD ;
Tsai, KY ;
Jacks, T .
NATURE CELL BIOLOGY, 2000, 2 (09) :563-568
[6]   A distinct microarray gene expression profile in primary rat hepatocytes incubated with ursodeoxycholic acid [J].
Castro, RE ;
Solá, S ;
Ma, XM ;
Ramalho, RM ;
Kren, BT ;
Steer, CJ ;
Rodrigues, CMP .
JOURNAL OF HEPATOLOGY, 2005, 42 (06) :897-906
[7]   p53 transcriptional activity is essential for p53-dependent apoptosis following DNA damage [J].
Chao, C ;
Saito, S ;
Kang, J ;
Anderson, CW ;
Appella, E ;
Xu, Y .
EMBO JOURNAL, 2000, 19 (18) :4967-4975
[8]   Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis [J].
Chipuk, JE ;
Kuwana, T ;
Bouchier-Hayes, L ;
Droin, NM ;
Newmeyer, D ;
Schuler, M ;
Green, DR .
SCIENCE, 2004, 303 (5660) :1010-1014
[9]   p53's believe it or not: Lessons on transcription-independent death [J].
Chipuk, JE ;
Green, DR .
JOURNAL OF CLINICAL IMMUNOLOGY, 2003, 23 (05) :355-361
[10]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825